Last reviewed · How we verify

NCT05695404: 3DiLUNG

Contribution of 3D Printing in Anatomical Lung Segmentectomies.

Completed Last updated 25 January 2023
What this trial tests

trial testing Segmentectomy in Thoracic Surgery in 34 participants. Completed in 5 October 2021.

Timeline
28 October 2020
Primary endpoint
5 October 2021
5 October 2021

Quick facts

Lead sponsorInstitut Mutualiste Montsouris
StatusCompleted
Study typeOBSERVATIONAL
Enrollment34
Start date28 October 2020
Primary completion5 October 2021
Estimated completion5 October 2021
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Institut Mutualiste Montsouris — full company profile →

Who can join

Eligibility, any sex, with Thoracic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present work was to evaluate if the presence on the operating field of a 3D printed personalized model of the pulmonary anatomy of a patient operated by full thoracoscopy for an anatomical segmentectomy, makes it possible to reduce the mental workload and the fatigue of the surgeon.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Segmentectomy

Trials testing the same drug.

Other recruiting trials for Thoracic Surgery

Currently open trials in the same condition.

Other Institut Mutualiste Montsouris trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05695404.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing